Late-stage COVID-19 vaccine trial fully enrolled, says Johnson & Johnson

It’s unit Jannsen, plans to submit an emergency use authorisation application to the U.S. Food and Drug Administration (FDA) in February

from The Hindu - International https://ift.tt/3p0ZNfV